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http://www.molecular-cancer.com/content/13/1/36RESEARCH Open AccesscAMP signaling inhibits radiation-induced ATM
phosphorylation leading to the augmentation of
apoptosis in human lung cancer cells
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Background: The ataxia–telangiectasia mutated (ATM) protein kinase plays a central role in coordinating the
cellular response to radiation-induced DNA damage. cAMP signaling regulates various cellular responses including
metabolism and gene expression. This study aimed to investigate the mechanism through which cAMP signaling
regulates ATM activation and cellular responses to ionizing radiation in lung cancer cells.
Methods: Lung cancer cells were transfected with constitutively active stimulatory G protein (GαsQL), and
irradiated with γ-rays. The phosphorylation of ATM and protein phosphatase 2A was analyzed by western blotting,
and apoptosis was assessed by western blotting, flow cytometry, and TUNNEL staining. The promoter activity of
NF-κB was determined by dual luciferase reporter assay. BALB/c mice were treated with forskolin to assess the effect
in the lung tissue.
Results: Transient expression of GαsQL significantly inhibited radiation-induced ATM phosphorylation in H1299
human lung cancer cells. Treatment with okadaic acid or knock down of PP2A B56δ subunit abolished the
inhibitory effect of Gαs on radiation-induced ATM phosphorylation. Expression of GαsQL increased phosphorylation
of the B56δ and PP2A activity, and inhibition of PKA blocked Gαs-induced PP2A activation. GαsQL enhanced
radiation-induced cleavage of caspase-3 and PARP and increased the number of early apoptotic cells. The
radiation-induced apoptosis was increased by inhibition of NF-κB using PDTC or inhibition of ATM using KU55933
or siRNA against ATM. Pretreatment of BALB/c mice with forskolin stimulated phosphorylation of PP2A B56δ,
inhibited the activation of ATM and NF-κB, and augmented radiation-induced apoptosis in the lung tissue. GαsQL
expression decreased the nuclear levels of the p50 and p65 subunits and NF-κB-dependent activity after γ-ray
irradiation in H1299 cells. Pretreatment with prostaglandin E2 or isoproterenol increased B56δ phosphorylation,
decreased radiation-induced ATM phosphorylation and increased apoptosis.
Conclusions: cAMP signaling inhibits radiation-induced ATM activation by PKA-dependent activation of PP2A, and
this signaling mechanism augments radiation-induced apoptosis by reducing ATM-dependent activation of NF-κB
in lung cancer cells.
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Radiotherapy is one of the major treatment modalities
for benign and malignant diseases throughout the body.
Approximately 50% of all cancer patients are treated
with radiotherapy, and there is a wide inter-patient vari-
ability in tumor responses. Strategies to improve radio-
therapy seek to increase the effects of radiation on the
tumor or decrease the effects on normal tissues. An im-
proved understanding of the molecular response of cells
and tissues to ionizing radiation has contributed to im-
provements in radiotherapy [1]. Ionizing radiation can
induce single-strand breaks (SSBs) and double-strand
breaks (DSBs) in the DNA double helix backbone that
trigger DNA damage responses. The DNA damage re-
sponse machinery delays cell cycle progression and acti-
vates cell cycle checkpoints to provide more time for
lesion repair and prevent the transfer of damaged DNA to
progeny. When repair fails, the damaged cells are com-
monly eliminated from the proliferative pool through cel-
lular senescence or several types of cell death, including
apoptosis [2].
Together with ataxia–telangiectasia and RAD3-related
(ATR) and DNA-dependent protein kinase catalytic sub-
unit (DNA-PKcs), the ataxia–telangiectasia mutated
(ATM) protein kinase plays a central role in coordinating
the cellular response to DNA damage [3-5]. Deficiency in
the ATM kinase causes ataxia-telangiectasia, a rare auto-
somal recessive disorder characterized by hypersensitivity
to radiation and predisposition to cancer. ATM belongs to
the phosphatidylinositol 3 kinase-like kinase (PIKK) family
of Ser/Thr-protein kinases, which contains ATR, DNA-
PKcs and mTOR (mammalian target of rapamycin) [6].
Following DNA damage, an intermolecular autophospho-
rylation occurs on Ser-1981 of ATM that disrupts the in-
active homodimer and enables the kinase domain to
phosphorylate several target substrates and trigger down-
stream signaling pathways [5]. Many ATM substrates
regulate gene expression, cell-cycle checkpoints, DNA re-
pair and apoptosis [7]. Thus, ATM is a potential target mol-
ecule for the development of novel radiosensitizers [8,9].
Cyclic adenosine 3', 5'-monophosphate (cAMP) is a
second messenger that is produced from ATP by ad-
enylate cyclases and degraded into 5’-AMP by cyclic
nucleotide phosphodiesterases. Adenylate cyclase is ac-
tivated by stimulatory heterotrimeric GTP-binding
proteins (G proteins), which are activated by G protein
coupled receptor (GPCR)-agonist complexes [10].
cAMP binds to and activates the cAMP-dependent
protein kinase (PKA), the cAMP-activated guanine ex-
change factors (Epacs), which are the guanine nucleo-
tide exchange factors (GEFs) for monomeric G protein
Raps [11], and the cyclic nucleotide-gated channels
functioning in transduction of sensory signals (CNGs).
The cAMP signaling system regulates numerous cellularresponses including gene expression, growth, differenti-
ation, proliferation, and apoptosis.
We have reported that the cAMP signaling system
modulates cancer cell apoptosis by regulating the ex-
pression of Bcl-2 family proteins [12,13] and the inhibi-
tor of apoptosis protein (IAP) [14] in response to
various DNA damaging agents, including ionizing radi-
ation. Recently, the cAMP signaling system was found to
inhibit the repair of γ-ray-induced DNA damage by pro-
moting degradation of the XRCC1 protein in human
lung cancer cells [15]. The cAMP signaling system was
also reported to inhibit DNA-damage induced apoptosis
of leukemia cells by promoting acetylation and turnover
of p53 [16,17]. Thus, we hypothesized that the cAMP
signaling system might be involved in the regulation of
ATM activation, the key event triggering signaling path-
ways in response to DNA damage. This study aimed to
investigate the mechanism through which the cAMP
signaling system regulates ATM activation and cellular
responses following γ-ray irradiation. We found that
Gαs inhibits ATM activation via the Gαs-cAMP-PKA-
PP2A pathway and augments radiation-induced apop-
tosis following γ-ray irradiation in non-small cell lung
cancer cells.
Results
Gαs inhibited radiation-induced ATM activation in lung
cancer cells
To investigate the effects of cAMP signaling on radiation-
induced DNA damage responses, an EE-tagged consti-
tutively active mutant long form of the α subunit of
stimulatory heterotrimeric GTP binding protein (GαsQL)
was transiently expressed in H1299 human lung cancer
cells. Irradiation of H1299 cells with γ-rays induced a bi-
phasic phosphorylation of ATM: ATM phosphorylation
started at 15 min after irradiation and reached peak levels
at 30 min, followed by a second peak at 120 min. Expres-
sion of GαsQL decreased the peak level of ATM phos-
phorylation at 30 min and displayed the initial peak at
90 min after irradiation (Figure 1A & Additional file 1:
Figure S1). GαsQL expression significantly inhibited the
radiation-induced phosphorylation of ATM and H2AX
30 min after γ-ray irradiation in H1299 cells, without
changing their protein levels; the expression of Rad50,
Ku70, and Ku80 also remained unchanged (Figure 1B).
The densitometric analyses of the blots confirmed the
decrease in ATM and H2AX phosphorylation by GαsQL
(Figure 1C). GαsQL expression also inhibited the radiation-
induced phosphorylation of ATM in A594 lung cancer cells
(Figure 1D). Both western blot analysis of the subcellular
fractions (Figure 1E) and confocal microscopic analysis
(Figure 1F) showed that Gαs inhibited radiation-induced
ATM activation in the nucleus within 1 h after γ-ray ex-
posure. Furthermore, to confirm the inhibition of ATM
Figure 1 (See legend on next page.)
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Figure 1 Gαs inhibited ATM activation induced by γ−ray irradiation in lung cancer cells. (A) Effect of Gαs on the phosphorylation of ATM
following γ-ray irradiation in H1299 lung cancer cells. (B) Effect of Gαs on the proteins involved in DNA damage responses following γ-ray irradiation in
H1299 cells. L represents the long forms of Gαs, and S represents the short forms of Gαs. (C) Densitometric analysis of the phosphorylation of ATM and
H2AX. The histograms represent the means and standard errors of at least three independent experiments (empty bar: p-ATM, filled bar: ATM, diagonal
bar: γ-H2AX, and hatched bar: H2AX), and an asterisk (*) indicates a statistically significant difference from the vector-transfected control cells (p < 0.05,
Mann–Whitney U test). (D) Effect of Gαs on the phosphorylation of ATM following γ-ray irradiation in A549 lung cancer cells. (E) Subcellular fractionation
analysis of ATM phosphorylation. (F) Confocal microscopic analysis of ATM phosphorylation. Lung cancer cells (H1299 and A549 cells) were transfected
with EE-tagged GαsQL or a pcDNA3 vector (V), incubated for 24 h, and irradiated with γ-rays (5 Gy). After incubation for 30 min or for the indicated times,
the expression and phosphorylation of the proteins involved in DNA damage responses were analyzed by western blotting. Each lane represents cells
that were separately transfected, and β-actin was used as a loading control. Thirty minutes after irradiation, the cells were lysed and fractionated
for western blotting. COX-1 and PARP were used as markers for cytosolic and nuclear fractions, respectively. One hour after irradiation, phosphorylated
ATM was assessed by staining with p-ATM-FITC (green) and DAPI (blue), and the samples were then analyzed by confocal microscopy.
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target molecules: p53 and CHK2 was analyzed. GαsQL
expression decreased radiation-induced phosphorylation
of p53 in A549 cells, and CHK2 in H1299 and A549 cells
(Additional file 1: Figure S2). In addition, treatment with
N6-benzoyl cAMP, a PKA selective cAMP analogue,
also inhibited radiation-induced ATM phosphorylation
(Additional file 1: Figure S3). These results show that Gαs
inhibits radiation-induced ATM activation at the early
phase of the DNA damage response in lung cancer cells.Gαs activated PP2A in a PKA-dependent manner, causing
the inhibition of radiation-induced phosphorylation of
ATM in H1299 lung cancer cells
To investigate the mechanism through which Gαs inhib-
ited radiation-induced ATM phosphorylation, the effect
of a PP2A inhibitor, okadaic acid, on ATM phosphoryl-
ation was analyzed. It was because the phosphorylation
level of proteins including ATM is regulated by both the
protein kinases and phosphatases, and because ATM is
not as a known PKA substrate but known to be dephos-
phorylated by PP2A which is activated by PKA. Treat-
ment with okadaic acid abolished the inhibitory effect of
Gαs on radiation-induced ATM phosphorylation and re-
covered the phosphorylation to the control level in the
GαsQL-transfected cells (Figure 2A & Additional file 1:
Figure S5). Then, to examine whether Gαs could activate
PP2A, the phosphorylation of the PP2A B56δ subunit at
Ser-566 was analyzed in GαsQL-transfected cells. Expres-
sion of GαsQL strongly increased the basal phosphorylation
level of the B56δ subunit, and the increased B56δ subunit
phosphorylation was maintained after irradiation without
an observable change in the protein level (Figure 2B &
Additional file 1: Figure S6). Furthermore, knockdown
of PP2A B56δ subunit with siRNA abolished the inhibi-
tory effect of Gαs on radiation-induced ATM phosphor-
ylation (Fig 2B & Additional file 1: Figure S6). Next, to
determine if phosphorylation of the PP2A B56δ subunit
by Gαs was catalyzed by PKA, the effect of PKA inhib-
ition was assessed. Inhibition of PKA with the inhibitorH89 or a dominant negative PKA decreased the phos-
phorylation of PP2A B56δ before and after γ-ray irradi-
ation and resulted in a concomitant increase in ATM
phosphorylation (Figure 2C & Additional file 1: Figure S7).
The effective inhibition of PKA by H89 or a dominant
negative PKA was evidenced by a decrease in phosphory-
lated CREB, which is a well-known PKA target protein.
Then, the effect of Gαs signaling on PP2A enzyme activity
was analyzed. Expression of GαsQL increased PP2A activ-
ity before and after γ-ray irradiation compared with the
respective control, and the PP2A-activating effect of Gαs
was completely blocked by H89 or the dominant negative
PKA (Figure 2D). These results indicate that Gαs activates
PP2A by phosphorylating the B56δ subunit in a PKA-
dependent manner, which decreases radiation-induced
phosphorylation of ATM in H1299 lung cancer cells.Gαs augmented radiation-induced apoptosis by inhibiting
ATM activation in lung cancer cells and mouse lung tissue
To investigate the physiological effects of the inhibition of
radiation-induced ATM activation by Gαs, we examined the
effect on radiation-induced apoptosis. In H1299 cells, ex-
pression of GαsQL enhanced radiation-induced cleavage of
caspase 3 and PARP (Figure 3A). GαsQL expression also in-
creased the number of cells stained with annexin V but not
with propidium iodide following irradiation (Figure 3B &
Additional file 1: Figure S8), and decreased survival of irradi-
ated cells in clonogenic assay (Additional file 1: Figure S9).
Treatment with an ATM inhibitor, KU55933, also en-
hanced the radiation-induced cleavage of caspase 3 and
PARP and increased the proportion of annexin V-stained
cells (Figure 3A & B). Knockdown of ATM with siRNA
also enhanced the radiation-induced cleavage of caspase 3
and PARP (Figure 3C). In contrast, activation of ATM by
pretreatment with chloroquine decreased the radiation-
induced cleavage of caspase 3 and PARP (Figure 3D). In
addition, A549 human lung cancer cells were used to con-
firm that the observed effects of Gαs also occurred in
other lung cancer cells. Expression of GαsQL in A549






































































































































































Figure 2 Gαs activated PP2A in a PKA dependent manner, which decreased the radiation-induced phosphorylation of ATM in H1299
lung cancer cells. (A) Effect of okadaic acid (OA) on the radiation-induced ATM phosphorylation. (B) Effect of Gαs on PP2A B56δ phosphorylation.
(C) Effect of PKA inhibition on the phosphorylation of PP2A B56δ and ATM. (D) Effect of Gαs on PP2A activity. H1299 cells were transfected with GαsQL,
vector (V), or dominant negative PKA (dnPKA) and incubated for 24 h. siRNA against B56δ (siB56δ) or control siRNA was transfected and the cells were
incubated for 48 h before the treatment. The cells were pretreated with 500 nM okadaic acid, 10 μM H89, or DMSO as a vehicle for 30 min,
and then the cells were irradiated with γ-rays (5 Gy). After incubation for 30 min, the cells were harvested and analyzed by western blotting
and for PP2A activity. Phosphorylated AKT (p-AKT) was analyzed as a positive control for PP2A activity. Asterisks (*) on the histograms indicate a
statistically significant difference from the vector-transfected control cells; the double asterisks (**) represent a statistically significant difference
from the GαsQL-transfected control cells (p < 0.05, Mann–Whitney U test, D).
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V stained cells (Figure 3E & F). These results indicate that
Gαs augments the radiation-induced apoptosis by inhibit-
ing ATM activation in human lung cancer cells.
Next, BALB/c mice were used to verify the effect of Gαs
activation in vivo. Prior to the animal experiment, the ef-
fect of forskolin, an adenylate cyclase activator similar to
Gαs, was analyzed in B16-F10 mouse melanoma cells.
Treatment with forskolin increased the radiation-induced
phosphorylation of the PP2A B56δ subunit and decreased
the radiation-induced phosphorylation of ATM in the
melanoma cells (Figure 4A). Pretreatment of BALB/c mice
with forskolin stimulated phosphorylation of PP2A B56δ
and inhibited the phosphorylation of ATM in lung tissuefollowing γ-ray irradiation (Figure 4B). Furthermore, for-
skolin treatment of BALB/c mice increased radiation-
induced apoptosis in the lung tissue as evidenced by an
increased cleavage of caspase-3 and PARP (Figure 4C) and
an increase in TUNEL-stained cells following γ-ray irradi-
ation (Figure 4D). These results suggest that cAMP signal-
ing augments radiation-induced apoptosis by inhibiting
ATM activation via PP2A in mouse lung, as well as in hu-
man lung cancer cells and murine melanoma cells.
Gαs augmented radiation-induced apoptosis by reducing
ATM-dependent activation of NF-κB
To study the mechanism through which reduced ATM acti-






Figure 3 (See legend on next page.)
Cho et al. Molecular Cancer 2014, 13:36 Page 6 of 15
http://www.molecular-cancer.com/content/13/1/36
(See figure on previous page.)
Figure 3 Gαs augmented radiation-induced apoptosis by inhibiting ATM activation in lung cancer cells. (A) Effects of Gαs on
radiation-induced cleavage of caspase-3 and PARP in H1299 cells. (B) Effects of Gαs on radiation-induced early apoptosis in H1299 cells.
(C) Effects of ATM knockdown on radiation-induced cleavage of caspase-3 and PARP in H1299 cells. (D) Effect of chloroquine on radiation-induced
apoptosis in H1299 cells. (E) Effect of GαsQL on radiation-induced cleavage of caspase 3 and PARP in A549 cells. (F) Effects of Gαs on radiation-induced
early apoptosis in A549 cells. The cells were irradiated with γ-rays (5 Gy) and incubated for 30 min for analysis of ATM phosphorylation. For analysis of
apoptosis, the cells were pretreated with 10 μM KU55933 or DMSO for 30 min, irradiated with γ-rays (10 Gy) and incubated for 24 h. To determine the
effects of chloroquine, the cells were pretreated with 20 μg/ml chloroquine for 4 h before irradiation; the culture medium was replaced with fresh medium
at 1 h after irradiation. The cells were incubated for an additional 23 h, and then harvested and analyzed by western blotting or flow cytometry after
staining with annexin V and propidium iodide (PI). The histograms present the ratio of annexin V-positive but propidium iodide-negative cells, and asterisks
(*) on the histograms indicate a statistically significant difference from the vector-transfected control cells
































































Figure 4 Forskolin augmented radiation-induced apoptosis by inhibiting ATM activation in the mouse lung. (A) Effects of forskolin on
the phosphorylation of PP2A B56δ and ATM in B16F10 mouse melanoma cells. Mouse melanoma cells were pretreated with 40 μM forskolin for
30 min and irradiated with γ-rays (5 Gy). After incubation for 30 min, the phosphorylation of PP2A B56δ and ATM were analyzed by western
blotting. (B) Effects of forskolin on the phosphorylation of PP2A B56δ and ATM in the mouse lung. (C) Effect of forskolin on apoptosis in the
mouse lung analyzed by western blotting. (D) Effect of forskolin on apoptosis in the mouse lung analyzed by the TUNEL assay. Four-week-old
male BALB/c mice (20 g, n = 6) were injected intraperitoneally with forskolin (20 μg/g) or DMSO, and after 6 h, the mice were exposed to whole
body γ-ray irradiation (10 Gy). After incubation for 30 min, the animals were sacrificed, and the lung tissues were excised and homogenized for
western blot analysis of ATM and PP2A. For apoptosis analysis, the animals were sacrificed at 24 h after irradiation, and the lung tissues were
excised. A portion of the lung tissues were homogenized and analyzed for cleavage of caspase-3 and PARP by western blotting. The other
portion of the tissue was immediately fixed with formaldehyde and examined by the TUNEL assay. The arrows indicate the stained cells
undergoing apoptosis.








Figure 5 (See legend on next page.)
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Figure 5 Reduced ATM-dependent activation of NF-κB augmented radiation-induced apoptosis by Gαs. (A) Effect of NF-κB inhibitors on
radiation-induced cleavage of caspase 3 and PARP in H1299 cells. (B) Effect of constitutively active IKKα (IKKαSE) and IKKβ (IKKβSE) on on
radiation;-induced cleavage of caspase 3 and PARP in H1299 cells. (C, D) Effect of Gαs on the activation of NF-κB in H1299 cells. The graph was
made from the western blot band densities (empty bar: nuclear p50, filled bar: nuclear p65). (E) Effect of Gαs on NF-κB-dependent luciferase
activity in H1299 cells. The empty bar represents vector control and the filled bar GαsQL transfected cells. (F) Effect of ATM activity on NF-κB-dependent
luciferase activity in H1299 cells. (G) Effect of Gαs on NF-κB-dependent luciferase activity in A549 cells (H) Effect of Gαs on cytosolic pATM. Asterisks (*) on
the histograms indicate a statistically significant difference from the vector-transfected control cells; the double asterisks (**) represent a statistically
significant difference from the irradiated control cells; the triple asterisks (***) represent a statistically significant difference from the GαsQL-transfected
control cells (p < 0.05, Mann–Whitney U test). H1299 cells were pretreated with KU55933 (10 μM), or PDTC (5 μM), BAY 11–7082 (10 μM), or IKK inhibitor
VII (IKKi VII, 500 μM) for 30 min or chloroquine (20 μg/ml) for 4 h with/without transfection of GαsQL or vector. Then, the cells were irradiated
with γ-rays (10 Gy) and incubated for 24 h. NF-κB-dependent luciferase activity was assessed using the Dual-Luciferase Reporter Assay System.
The cells were also lysed and fractionated into nucleus and cytosol fraction before western blot analysis. PARP was the markers for nucleus fraction.
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to prevent apoptosis [18]. Inhibition of NF-κB by treatment
with NF-κB inhibitors such as PDTC, BAY 11–7082, and
IKK inhibitor VII increased the radiation-induced cleavage of
caspase-3 and PARP in H1299 cells (Figure 5A). Further-
more, activation of NF-κB by expression of constitutively ac-
tive IKKα and IKKβ reduced the cleavage of caspase-3 and
PARP augmented by GαsQL (Figure 5B), indicating in-
hibition of NF-κB activity augments radiation-induced
apoptosis. Next, the effect of radiation and Gαs on NF-
κB activation was examined. Radiation increased nu-
clear translocation of NF-kB p50 and p65 with a peak at
2 h after irradiation, and the expression of GαsQL
reduced the radiation-induced translocation of p50
and p65 (Figure 5C & D). Then, the effect on NF-κB-
dependent promoter activity was analyzed. Radiation
slightly increased NF-κB-dependent promoter activity,
and the expression of GαsQL reduced the promoter ac-
tivity until 24 h after irradiation (Figure 5E). Next, the
role of ATM in NF-κB activation was assessed. Inhibition
of ATM activation by treatment with an ATM inhibitor,
KU55933, or by knockdown with siRNA reduced the NF-
κB-dependent promoter activity before and 2 h after irradi-
ation (Figure 5F). Activation of ATM by pretreatment with
chloroquine abolished the reducing effect of GαsQL on
NF-κB-dependent promoter activity (Figure 5F). The ex-
pression of GαsQL also reduced the NF-κB activity before
and after irradiation in A549 lung cancer cells (Figure 5G).
These results suggest that Gαs augments radiation-
induced apoptosis by reducing ATM-dependent activa-
tion of NF-κB in lung cancer cells.
To probe the mechanism how ATM activate NF-kB
after irradiation, we determined the effect of Gαs on the
level of phosphorylated ATM in the cytosol, where IκBα
is located and degraded following phosphorylation. Al-
though most of the phosphorylated ATM is localized in
the nucleus, a small amount of phosphorylated ATM in
the cytosol could be visualized after γ-ray irradiation by
exposing blots to the gel documentation system for a
longer period of time. γ-Ray irradiation increased the
amount of phosphorylated ATM in the cytosol, and GαsQLexpression decreased the amount of phosphorylated ATM
in the cytosol following irradiation (Figure 5H). This result
indicates that Gαs reduced the translocation of phosphory-
lated ATM into the cytosol, which might decrease phos-
phorylation and degradation IκBα protein and reduce
activation of NF-κB in H1299 lung cancer cells.
Prostaglandin E2 and isoproterenol affected ATM
activation and apoptosis similarly to Gαs
To confirm the effects observed upon GαsQL expres-
sion, we analyzed the effects of prostaglandin E2 and
isoproterenol, two agonists for Gαs-coupled receptors.
Pretreatment with prostaglandin E2 and isoproterenol
increased the phosphorylation of PP2A B56δ and de-
creased ATM phosphorylation following γ-ray irradi-
ation (Figure 6A). Pretreatment with prostaglandin E2
decreased NF-κB luciferase activity 12 h after irradiation
and the activity was not recovered until 24 h after irradi-
ation. Isoproterenol treatment showed a similar inhibitory
effect on radiation-induced NF-κB-dependent promoter
activity (Figure 6B). The inhibitory effect of prostaglandin
E2 and isoproterenol on ATM phosphorylation was abol-
ished by treatment with a PKA inhibitor, H-89 (Additional
file 1: Figure S10). Prostaglandin E2 or isoproterenol treat-
ments also enhanced the cleavage of caspase-3 and PARP
(Figure 6C & Additional file 1: Figure S11) and increased
the proportion of early apoptotic H1299 cells (Figure 6D).
Moreover, treatment with prostaglandin E2 significantly
decreased survival of the irradiated cells (Additional file 1:
Figure S12). These results indicate that agonists for Gαs-
coupled receptors can activate PP2A and inhibit ATM
and NF-κB similar to Gαs and, thus, augment apoptosis
following γ-ray irradiation in H1299 cells (Figure 7).
Discussion
This study aimed to investigate the mechanism through
which the cAMP signaling system might regulate the ac-
tivation of ATM and apoptosis following γ-ray irradiation.
We found that cAMP signaling inhibits radiation-induced
activation of ATM by PKA-dependent activation of PP2A,
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Figure 6 Agonists for Gαs-coupled receptors inhibited ATM phosphorylation and augmented apoptosis following γ-ray irradiation in
H1299 cells. (A) Effects of prostaglandin E2 (PGE2) and isoproterenol (ISO) on PP2A B56δ and ATM phosphorylation. (B) Time-course of NF-κB
luciferase activity after prostaglandin E2 or isoproterenol treatment. (C) Effects of prostaglandin E2 and isoproterenol on the cleavage of caspase
3 and PARP. (D) Effects of prostaglandin E2 and isoproterenol on early apoptosis. H1299 cells were treated with 1 μM isoproterenol or 10 μM
PGE2 for 30 min before irradiation with γ-rays (5 Gy for or 10 Gy for others). Cells were then incubated for 30 min for analysis of phosphorylated
ATM, B56δ, and CREB or 24 h for apoptosis analysis. For NF-κB luciferase activity assays, cells transfected with the reporter genes were treated with
1 μM isoproterenol or 10 μM PGE2 at30 min before irradiation (10 Gy), and the luciferase activity was measured at the indicated times (empty
bar: control cells, filled bar: PGE2-treated cells, diagonal bar: isoproterenol-treated cells).
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dependent activation of NF-κB in human lung cancer
cells and mouse lung.
Our finding that the cAMP signaling system inhibits
radiation-induced activation of ATM by PKA-dependent
activation of PP2A is supported by several results. First,
radiation-induced phosphorylation of ATM was inhi-
bited by expression of constitutively active Gαs and by
treatment with Gαs-coupled receptor agonists or an ad-
enylate cyclase activator, forskolin. Second, treatment with
a PP2A inhibitor or knock down of PP2A B56δ subunit
abolished the ATM-inhibitory effect of Gαs. Third, ex-
pression of the active Gαs increased the phosphoryl-
ation of the PP2A B56δ subunit and enhanced PP2A
activity. In addition, inhibition of PKA abolished the
PP2A activation induced by Gαs, thereby restoring ATM
phosphorylation. Moreover, inhibition of radiation-inducedATM phosphorylation by the cAMP signaling system was
observed in human lung cancer cells, murine melanoma
cells, and murine lung tissue, suggesting that the inhibition
occurs in many tissues.
ATM is primarily recruited to double-strand DNA breaks
and activated through interactions with the MRE11–
RAD50–NBS1 (MRN) complex [19]. ATM protein under-
goes autophosphorylation at Ser-1981 and forms monomers
from an inactive dimer following double-strand DNA
breaks; ATM autophosphorylation is considered a hall-
mark of ATM activation [20]. Recently, ATM was found
to be activated independently from DNA damage through
redox-dependent mechanisms and to participate in di-
verse signaling pathways involved in metabolic regula-
tion and cancer [5]. However, no previous reports show
that the cAMP signaling system regulates radiation-


























Figure 7 A suggested model for cAMP signaling to inhibit radiation-induced ATM activation, which results in augmentation of
apoptosis in lung cancer.
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radioenhancer [8]. Caffeine is also known to inhibit cAMP
phosphodiesterase, which may increase the cAMP level
[21], suggesting the involvement of the cAMP signaling
system in ATM activation. However, caffeine was reported
to inhibit the enzymatic activity of ATM immunoprecipi-
tates in vitro, which was interpreted as direct inhibition of
ATM by caffeine [22], independent of the cAMP signaling
system. Thus, to the best of our knowledge, this paper
presents the first evidence that the cAMP signaling system
can regulate radiation-induced ATM activation.
PP2A-mediated inhibition of ATM activation in a PKA-
dependent pathway is supported by the previous report
that PKA phosphorylates Ser-566 of the PP2A B56δ
subunit to stimulate PP2A activity [23]. PP2A forms
complexes with ATM and dephosphorylates the autop-
hosphorylated Ser-1981 in undamaged cells to suppress
the intrinsic ATM activity [24].
This study shows that the cAMP signaling system
augments radiation-induced apoptosis by inhibiting
ATM activation. This finding is based on the result that
radiation-induced apoptosis was augmented by the activa-
tion of the cAMP signaling system and by inhibition of
ATM with a specific inhibitor, KU55933, and siRNA against
ATM in cancer cells and mouse lung. In addition, the
cAMP signaling system inhibits radiation-induced activa-
tion of ATM. This finding is supported by the fact that
ATM is a master regulator of cellular responses to DNA
damage caused by ionizing radiation and activates down-
stream signaling pathways to regulate various DNA damage
responses including cell cycle, DNA repair, and apoptosis
[25,26]. This finding suggests that cAMP signaling canmodulate radiation-induced apoptosis by regulating
radiation-induced ATM activation. This finding also
implies that drugs targeting the cAMP signaling path-
way could be possibly used to modulate radiation-
induced apoptosis, thereby increasing the radiosensi-
tivity of cancer cells or protecting normal cells from
radiation. The cAMP signaling system can stimulate or
inhibit apoptosis depending on cell types [27] through
diverse molecular mechanisms involving Bcl-2 family
proteins, p53, and histone deacetylase [16,28,29]. Thus,
this study presents a novel mechanism for the cAMP sig-
naling system to regulate cancer cell apoptosis. It is also
plausible that the cAMP signaling system modulates other
cellular responses to DNA damage mediated by ATM,
such as DNA damage repair and cell cycle arrest.
The cAMP signaling system was found to augment
radiation-induced apoptosis partly by inhibiting ATM-
mediated NF-κB activation in this study. This finding is
substantiated by the result that activation of the cAMP
signaling system or inhibition of ATM resulted in a re-
duction of radiation-induced NF-κB activation and
augmentation of apoptosis. In addition, inhibition of
NF-κB activation by treatment with several NF-κB spe-
cific inhibitors augmented radiation-induced apop-
tosis, but activation of NF-κB signaling by expression
of constitutively active IKKs abolished apoptosis-augmenting
effect of cAMP signaling system. ATM can stimulate NF-κB
activation, which induces the expression of anti-apoptotic
proteins to protect cells from apoptosis. Thus, inhibition
of ATM may compel the cells to undergo apoptosis as ob-
served in this study [30,31]. However, ATM can play con-
trasting roles in DNA damage-induced apoptosis, and
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target substrates such as p53, TRF1 [32] and NBS1 [33].
Therefore, ATM seems to show different apoptotic effects
depending on the cell type, DNA damage-inducing agent,
the severity of DNA damage, and the presence of func-
tional p53 [34].
NF-κB is activated in response to various immune and
inflammatory stimuli, and it is also activated by ionizing
radiation to protect damaged cells from apoptotic cell
death [35,36]. The signal transduction mechanisms that
link DNA damage to NF-κB activation are relatively
unknown, but signaling pathways involving ATM and
NF-κB essential modulator (NEMO) are reported to co-
operate to directly link DNA damage in the nucleus to
NF-κB activation in the cytosol [37]. ATM is involved in
the sequential post-translational modification of NEMO,
and ATM translocates in a calcium-dependent manner
to the cytosol and membrane [38]. Cytosolic ATM acti-
vates TGFβ-activated kinase (TAK1), which phosphor-
ylates IKKβ to trigger ubiquitin-proteasome dependent
degradation of IκB and NF-κB activation [18]. In agree-
ment with these findings, the cAMP signaling system
was observed to reduce the cytosolic translocation of
phosphorylated ATM accompanied with increased IκB
level following γ-ray irradiation in this study, which
may have resulted from inhibition of radiation-induced
ATM phosphorylation and could cause reduced NF-κB
activation and augmented apoptosis.
In this study, the role of the cAMP signaling system in
ATM, PP2A and NF-κB activation, as well as in apoptosis,
following γ-ray irradiation was assessed by activating the
signaling system using various mechanisms: expression of
constitutively active Gαs, treatment with Gαs-coupled re-
ceptor agonists such as isoproterenol for β-adrenergic re-
ceptors and prostaglandin E2 for prostanoid receptors, or
treatment with the adenylate cyclase activator forskolin.
Furthermore, similar effects were observed in A549 and
p53-null H1299 human lung cancer cells, murine mel-
anoma cells, and murine lung tissue, suggesting com-
parable effects of the cAMP signaling system in various
cells and tissues. These results reinforce the inhibitory
role of the cAMP pathway in radiation-induced activa-
tion of ATM by PKA-dependent activation of PP2A.
These findings also suggest the augmentation of radiation-
induced apoptosis potentially through a reduction of ATM-
dependent NF-κB activation.
Conclusion
The cAMP signaling system inhibits radiation-induced ac-
tivation of ATM by PKA-dependent activation of PP2A,
thereby augmenting radiation-induced apoptosis in part
by reducing ATM-dependent activation of NF-κB in lung
cancer cells and mouse lung tissue (Figure 7). These find-
ings provide a novel mechanism through which the cAMPsignaling system regulates radiation-induced ATM activa-
tion and apoptosis, and these findings suggest that the
cAMP signaling system can be used to modulate DNA
damage responses to enhance the therapeutic efficiency of
radiation treatment for non-small cell lung cancers.
Methods
Cell culture and reagents
Human non-small cell lung cancer cell lines H1299 and
A549 (Korea Cell Line Bank, Seoul, Korea) and B16-F10
mouse melanoma cells (ATCC, Manassas, VA, USA)
were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) containing 10% fetal bovine serum (JBI, Korea)
and 100 units/ml penicillin/streptomycin. The cells were
incubated in a 5% CO2 incubator at 37°C. H89, iso-
proterenol, dimethyl sulfoxide (DMSO), and 4,6-diami-
dino-2-phenylindole dihydrochloride (DAPI) were
purchased from Sigma (St. Louis, MO, USA). Forskolin,
pyrrolidine dithiocarbamate (PDTC), IKK inhibitor VII,
BAY 11–7082 and isobutylmethylxanthine (IBMX) were
purchased from Calbiochem (La Jolla, CA, USA). The
FITC Annexin V apoptosis detection kit was purchased
from BD Biosciences (San Diego, CA, USA). Prostaglan-
din E2 (PGE2) and okadaic acid were purchased from
Cayman Chemical (Ann Arbor, MI, USA). KU-55933
was purchased from Selleck Chemicals (Houston, TX,
USA). Bovine serum albumin (BSA) and goat anti-rabbit
IgG-FITC were purchased from Santa Cruz Biotechnol-
ogy (CA USA). Phenylmethanesulfonyl fluoride (PMSF),
sodium orthovanadate, sodium fluoride, and a protease
inhibitor mixture were purchased from Roche Molecular
Biochemicals (Indianapolis, IN, USA).
Animal experiment
Care, use, and treatment of animals were done in agree-
ment with the guidelines established by the Seoul National
University Institutional Animal Care and Use Committee
(SNU- 110415–2). Male BALB/c mice (4 week-old) were
housed for 1 week before the experiments and maintained
on a 12-h light/dark cycle, with food and water freely
available. The mice were divided into the control (n = 6)
and the treatment (n = 6) group. The treatment group
mice were injected intraperitoneally with forskolin (20 μg/g),
and the control mice received an equal volume of
Dulbecco's Phosphate-Buffered Saline. After 6 h, the mice
were exposed to whole body γ-ray irradiation (10 Gy).
Expression constructs and transient transfection
H1299 cells were transfected with a EE-tagged constitu-
tively active mutant (GαsQ227L, GαsQL) of long form
stimulatory α subunit of G protein (Gαs) in a pcDNA3
vector (Invitrogen, Paisley, UK) using the calcium phos-
phate method [39]. A glutamine residue that is essential
for the intrinsic GTPase activity is replaced with leucine in
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was a gift from Dr. G. Stanley McKnight (University of
Washington, WA, USA) [41]. Constitutively active mutant
of I-kappa B kinase alpha S176E/S180E (IKKαSE) and beta
S177E/181E (IKKβSE) were gifts from Dr. Dae-Myung Jue
(The Catholic University of Korea) [42]. Small interfering
RNAs (siRNAs) against ATM (cat. sc-29761) were pur-
chased from Santa Cruz Biotechnology (CA, USA), and
siRNA against PP2A B56δ (FlexiTube no. SI2653350)
from Qiagen (Hilden, Germany). Control siRNA (5’-
AATTCTCCGAACGTGTCACGT-3’) were purchased
from Bioneer (Daejeon, Korea). siRNAs were trans-
fected using Lipofectaimine (Invitrogen, Paisley, UK),
and the cells were treated with other reagents at 48 h
after transfection.Preparation of cytosolic and nuclear fractions
The cultured cells were harvested and then disrupted in
lysis buffer A (0.33 M sucrose, 10 mM Hepes (pH 7.4),
1 mM MgCl2, 0.1% Triton X-100, protease inhibitor
cocktail (PIC), and PMSF). The cell lysates were centri-
fuged for 5 min at 800 g, and the supernatants were col-
lected to use as the cytosolic fractions. The resulting
pellets were resuspended in lysis buffer B (0.45 M NaCl,
10 mM Hepes (pH 7.4), PIC, and PMSF) and centrifuged
for 5 min at 20,000 g. The supernatants were collected
to use as the nuclear fractions.Western blot analysis
Western blotting was performed as previously described
[28]. Antibodies against Gαs, Ku70, ATM, COX-1, phos-
phorylated cAMP response element binding protein
(p-CREB, Ser-133), PP2A B56δ, IκBα, p50 and p65 of
NF-κB were obtained from Santa Cruz Biotechnology
(CA, USA). Antibodies against Rad50, p-ATM (Ser-1981),
γ-H2AX, Ku80, CREB, DNA-PKcs, poly (ADP-ribose)
polymerase (PARP), cleaved caspase-3 (Asp-175), p-AKT
(Ser-473), AKT, p-IκBα, and Myc-tag were obtained from
Cell Signaling Technology (Beverly, MA, USA). An anti-
body against β-actin was purchased from Sigma (St. Louis,
MO, USA), and an antibody against EE-tag was purchased
from Covance (Princeton, NJ, USA). An antibody against
phosphorylated B56δ (Ser-566) of protein phosphatase 2A
(PP2A) was kindly provided by Dr. Paul Greengard (The
Rockefeller University, New York) [23]. The proteins were
visualized using the Enhanced Chemiluminescence (ECL)
reagent (Thermo scientific, Waltham, MA) and de-
tected using an LAS-3000 (R&D Systems, Inc. Minne-
apolis, MN, USA). The densities of the protein bands
were quantified using the Multi Gauge v2.3 software
(Fuji, Tokyo, Japan), and the relative band densities
were expressed as ratios of the corresponding control
densities.Immunofluorescence microscopy
H1299 cells were plated in 60 mm dishes and incubated
until they became 60% confluent. The cells were trans-
fected with vector or GαsQL plasmids, and after 24 h,
they were irradiated with γ-rays (5 Gy) from a cesium
(Cs) irradiator [15]. After 30 min, the cells were fixed
with 4% paraformaldehyde for 20 min and permeated
with 0.5% Triton X-100 for 10 min. After blocking with
2% BSA for 1 h, the cells were incubated overnight with
an antibody against p-ATM (1:200) in 2% BSA, followed
by incubation with goat anti-rabbit IgG-FITC (1:100)
and DAPI (0.5 μl/ ml) for 1 h. The stained cells were ob-
served with a confocal microscope (LSM 501 META,
Carl Zeiss, Inc. USA).
TUNEL assay
Extracted lung tissues from BALB/c mice were deparaffi-
nized and hydrated. The tissues were stained using the
ApopTag fluorescein in situ apoptosis detection kit
(Chemicon International, Temecula, CA, USA), and
apoptosis was observed using confocal laser scanning
microscopy (TCS SP2, Leica, Wetzler, Germany).
PP2A activity assay
Cells were prepared and lysed following the protocol of
the PP2A activity assay kit (R&D Systems, Inc. Minne-
apolis, MN, USA). In brief, the cell lysates were incu-
bated with Serine/Threonine Phosphatase substrate I
for 30 min, and then, 10 μl of Malachite Green Reagent
A was added and incubated for 10 min. Then, 10 μl of
Malachite Green Reagent B was added and incubated
for 20 min, and the absorbance at 620 nm was measured
with the Benchmark Plus™ microplate reader (Bio-Rad,
PA, USA).
Flow cytometry
The cells were exposed to γ-rays (10 Gy) and incubated
for 24 h. Then, the cells were washed twice with
phosphate-buffered saline, harvested, and spun at 3,500 g
for 5 min at 4°C. The cells were incubated in 1X Annexin
V buffer containing Annexin V and PI for 15 min. Stained
cells were quantified with a FacsCalibur flow cytometer
(BD Biosciences, Franklin Lakes, NJ, USA) using 10,000
cells per measurement.
Dual luciferase reporter assay
H1299 cells were transfected with plasmids containing lu-
ciferase reporter genes (NF-κB-pLuc and Renilla-pLuc) to-
gether with vector or GαsQL plasmids using the calcium
phosphate method. Luciferase activities were measured
using the Dual-Luciferase Reporter Assay System (Pro-
mega Corp., Madison, WI, USA) according to the manu-
facturer’s protocol. At least four independent experiments
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normalized using Renilla luciferase activity.
Data analysis
At least three or more independent experiments were
conducted for all the analyses, and the data were pre-
sented as the means ± standard errors (SE). The non-
parametric Mann–Whitney U test was used to analyze
the mean values, and a p value of less than 0.05 was con-
sidered statistically significant.
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